Last week, the Department of Justice charged the president of a medical technology company for acts related to promoting a fake COVID-19 test. The case demonstrates the government’s vigilance in prosecuting COVID-19-related fraud, and warns all businesses to avoid making misrepresentations when responding to COVID-19.

Click here to read more.